These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8891611)

  • 1. Mapping the receptor domains critical for the binding selectivity of delta-opioid receptor ligands.
    Meng F; Ueda Y; Hoversten MT; Thompson RC; Taylor L; Watson SJ; Akil H
    Eur J Pharmacol; 1996 Sep; 311(2-3):285-92. PubMed ID: 8891611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A chimeric analysis of the opioid receptor domains critical for the binding selectivity of mu opioid ligands.
    Watson B; Meng F; Akil H
    Neurobiol Dis; 1996 Feb; 3(1):87-96. PubMed ID: 9173916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A chimeric study of the molecular basis of affinity and selectivity of the kappa and the delta opioid receptors. Potential role of extracellular domains.
    Meng F; Hoversten MT; Thompson RC; Taylor L; Watson SJ; Akil H
    J Biol Chem; 1995 May; 270(21):12730-6. PubMed ID: 7759527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on mu and delta opioid receptor selectivity utilizing chimeric and site-mutagenized receptors.
    Wang WW; Shahrestanifar M; Jin J; Howells RD
    Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12436-40. PubMed ID: 8618916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the amino acid residues in the sixth transmembrane domains accessible in the binding-site crevices of mu, delta, and kappa opioid receptors.
    Xu W; Li J; Chen C; Huang P; Weinstein H; Javitch JA; Shi L; de Riel JK; Liu-Chen LY
    Biochemistry; 2001 Jul; 40(27):8018-29. PubMed ID: 11434771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The region in the mu opioid receptor conferring selectivity for sufentanil over the delta receptor is different from that over the kappa receptor.
    Zhu J; Xue JC; Law PY; Claude PA; Luo LY; Yin J; Chen C; Liu-Chen LY
    FEBS Lett; 1996 Apr; 384(2):198-202. PubMed ID: 8612823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endomorphin-1 discriminates the mu-opioid receptor from the delta- and kappa-opioid receptors by recognizing the difference in multiple regions.
    Ide S; Sakano K; Seki T; Awamura S; Minami M; Satoh M
    Jpn J Pharmacol; 2000 Aug; 83(4):306-11. PubMed ID: 11001176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of Trp-284, Val-296, and Val-297 of the human delta-opioid receptor in binding of delta-selective ligands.
    Valiquette M; Vu HK; Yue SY; Wahlestedt C; Walker P
    J Biol Chem; 1996 Aug; 271(31):18789-96. PubMed ID: 8702536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irreversible binding of cis-(+)-3-methylfentanyl isothiocyanate to the delta opioid receptor and determination of its binding domain.
    Zhu J; Yin J; Law PY; Claude PA; Rice KC; Evans CJ; Chen C; Yu L; Liu-Chen LY
    J Biol Chem; 1996 Jan; 271(3):1430-4. PubMed ID: 8576134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The third extracellular loop of the human delta-opioid receptor determines the selectivity of delta-opioid agonists.
    Varga EV; Li X; Stropova D; Zalewska T; Landsman RS; Knapp RJ; Malatynska E; Kawai K; Mizusura A; Nagase H; Calderon SN; Rice K; Hruby VJ; Roeske WR; Yamamura HI
    Mol Pharmacol; 1996 Dec; 50(6):1619-24. PubMed ID: 8967985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 3D model of the delta opioid receptor and ligand-receptor complexes.
    Alkorta I; Loew GH
    Protein Eng; 1996 Jul; 9(7):573-83. PubMed ID: 8844829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DAMGO, a mu-opioid receptor selective ligand, distinguishes between mu-and kappa-opioid receptors at a different region from that for the distinction between mu- and delta-opioid receptors.
    Minami M; Onogi T; Nakagawa T; Katao Y; Aoki Y; Katsumata S; Satoh M
    FEBS Lett; 1995 May; 364(1):23-7. PubMed ID: 7750536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of opioid ligand-receptor interaction models: the structural basis of mu vs delta selectivity.
    Mosberg HI; Fowler CB
    J Pept Res; 2002 Dec; 60(6):329-35. PubMed ID: 12464111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid receptor three-dimensional structures from distance geometry calculations with hydrogen bonding constraints.
    Pogozheva ID; Lomize AL; Mosberg HI
    Biophys J; 1998 Aug; 75(2):612-34. PubMed ID: 9675164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo design, synthesis, and biological activities of high-affinity and selective non-peptide agonists of the delta-opioid receptor.
    Liao S; Alfaro-Lopez J; Shenderovich MD; Hosohata K; Lin J; Li X; Stropova D; Davis P; Jernigan KA; Porreca F; Yamamura HI; Hruby VJ
    J Med Chem; 1998 Nov; 41(24):4767-76. PubMed ID: 9822547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of 4-(N,N-diarylamino)piperidines with high selectivity to the delta-opioid receptor: a combined 3D-QSAR and ligand docking study.
    Podlogar BL; Poda GI; Demeter DA; Zhang SP; Carson JR; Neilson LA; Reitz AB; Ferguson DM
    Drug Des Discov; 2000; 17(1):34-50. PubMed ID: 10928448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Structure of mu and delta opioid receptors].
    Granier S
    Med Sci (Paris); 2012 Oct; 28(10):870-5. PubMed ID: 23067419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel "restoration of function" mutagenesis strategy to identify amino acids of the delta-opioid receptor involved in ligand binding.
    Pepin MC; Yue SY; Roberts E; Wahlestedt C; Walker P
    J Biol Chem; 1997 Apr; 272(14):9260-7. PubMed ID: 9083060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DAMGO, a mu-opioid receptor selective agonist, distinguishes between mu- and delta-opioid receptors around their first extracellular loops.
    Onogi T; Minami M; Katao Y; Nakagawa T; Aoki Y; Toya T; Katsumata S; Satoh M
    FEBS Lett; 1995 Jan; 357(1):93-7. PubMed ID: 8001688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.